| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24 | 1.76e-15 | 37 | 99 | 10 | GO:0004190 |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24 | 2.37e-15 | 38 | 99 | 10 | GO:0070001 |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 TPSAB1 PAMR1 CAPN3 ERVK-7 ERVK-21 ERVK-9 ERVK-10 TPSD1 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24 MMP17 TPSB2 TMPRSS11A | 3.68e-11 | 430 | 99 | 17 | GO:0004175 |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 TPSAB1 PAMR1 CAPN3 ERVK-7 ERVK-21 ERVK-9 ERVK-10 TPSD1 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24 MMP17 TPSB2 USP47 TMPRSS11A | 3.15e-09 | 654 | 99 | 18 | GO:0008233 |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 5.23e-09 | 14 | 99 | 5 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.83e-07 | 11 | 99 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 1.19e-06 | 38 | 99 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 3.19e-06 | 21 | 99 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 6.22e-06 | 262 | 99 | 9 | GO:0140097 | |
| GeneOntologyMolecularFunction | structural molecule activity | ERVK-6 CAPN3 ERVK-7 ERVK-21 ERVK-9 ERVK-10 SPON1 ASPH ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24 MUC4 MYBPC3 | 3.19e-05 | 891 | 99 | 15 | GO:0005198 |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 3.31e-05 | 37 | 99 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | folic acid receptor activity | 7.28e-05 | 3 | 99 | 2 | GO:0061714 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 7.91e-05 | 46 | 99 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 9.14e-05 | 18 | 99 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | transition metal ion binding | ERVK-6 CYP1B1 NAPEPLD ERVK-7 ERVK-21 ERVK-9 ERVK-10 F8 LOX SUMF1 RECQL4 ERVK-8 ERVK-19 KDM4A ERVK-24 MMP17 | 2.37e-04 | 1189 | 99 | 16 | GO:0046914 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 3.54e-04 | 28 | 99 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | endonuclease activity | 5.83e-04 | 136 | 99 | 5 | GO:0004519 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 6.42e-04 | 79 | 99 | 4 | GO:0004521 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | ERVK-6 SGIP1 PI4K2A ERVK-7 ERVK-10 STK32C ACVR1B LCK MST1R FAM20B ERVK-8 IKBKB WNK2 | 7.31e-04 | 938 | 99 | 13 | GO:0016772 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 8.13e-04 | 37 | 99 | 3 | GO:0045505 | |
| GeneOntologyMolecularFunction | volume-sensitive anion channel activity | 8.56e-04 | 9 | 99 | 2 | GO:0005225 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 9.63e-04 | 152 | 99 | 5 | GO:0016779 | |
| GeneOntologyMolecularFunction | structural constituent of muscle | 1.26e-03 | 43 | 99 | 3 | GO:0008307 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERVK-6 SGIP1 NTHL1 CHD1 ERVK-7 ERVK-10 CRY2 RECQL4 ERVK-8 HELZ | 1.36e-03 | 645 | 99 | 10 | GO:0140640 |
| GeneOntologyMolecularFunction | zinc ion binding | ERVK-6 NAPEPLD ERVK-7 ERVK-21 ERVK-9 ERVK-10 RECQL4 ERVK-8 ERVK-19 KDM4A ERVK-24 MMP17 | 1.51e-03 | 891 | 99 | 12 | GO:0008270 |
| GeneOntologyMolecularFunction | titin binding | 2.13e-03 | 14 | 99 | 2 | GO:0031432 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 2.57e-03 | 190 | 99 | 5 | GO:0004252 | |
| GeneOntologyBiologicalProcess | DNA integration | 3.45e-07 | 13 | 99 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 5.57e-05 | 85 | 99 | 5 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 5.57e-05 | 85 | 99 | 5 | GO:0000768 | |
| GeneOntologyBiologicalProcess | syncytium formation | 6.94e-05 | 89 | 99 | 5 | GO:0006949 | |
| GeneOntologyBiologicalProcess | viral process | ERVK-6 CHD1 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-8 ERVK-19 ERVK-24 TMPRSS11A | 7.86e-05 | 464 | 99 | 10 | GO:0016032 |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 8.26e-05 | 48 | 99 | 4 | GO:0000731 | |
| GeneOntologyBiologicalProcess | drinking behavior | 8.31e-05 | 18 | 99 | 3 | GO:0042756 | |
| GeneOntologyBiologicalProcess | feeding behavior | 1.31e-04 | 162 | 99 | 6 | GO:0007631 | |
| GeneOntologyCellularComponent | dynein complex | 1.35e-04 | 54 | 101 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 2.33e-04 | 25 | 101 | 3 | GO:0005858 | |
| Domain | - | 3.55e-05 | 333 | 91 | 9 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 3.72e-05 | 335 | 91 | 9 | IPR015943 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.92e-05 | 14 | 91 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 3.92e-05 | 14 | 91 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 3.92e-05 | 14 | 91 | 3 | IPR013602 | |
| Domain | DHC_N2 | 3.92e-05 | 14 | 91 | 3 | PF08393 | |
| Domain | MT | 3.92e-05 | 14 | 91 | 3 | PF12777 | |
| Domain | AAA_8 | 3.92e-05 | 14 | 91 | 3 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 3.92e-05 | 14 | 91 | 3 | IPR011704 | |
| Domain | AAA_5 | 3.92e-05 | 14 | 91 | 3 | PF07728 | |
| Domain | DHC_fam | 4.88e-05 | 15 | 91 | 3 | IPR026983 | |
| Domain | Dynein_heavy_dom | 4.88e-05 | 15 | 91 | 3 | IPR004273 | |
| Domain | Dynein_heavy | 4.88e-05 | 15 | 91 | 3 | PF03028 | |
| Domain | WD40 | 4.92e-05 | 268 | 91 | 8 | SM00320 | |
| Domain | WD40_repeat | 5.46e-05 | 272 | 91 | 8 | IPR001680 | |
| Domain | WD_REPEATS_2 | 6.53e-05 | 279 | 91 | 8 | PS50082 | |
| Domain | WD_REPEATS_REGION | 6.53e-05 | 279 | 91 | 8 | PS50294 | |
| Domain | TRYPSIN_SER | 1.69e-04 | 106 | 91 | 5 | PS00135 | |
| Domain | TRYPSIN_HIS | 1.77e-04 | 107 | 91 | 5 | PS00134 | |
| Domain | Peptidase_S1A | 2.28e-04 | 113 | 91 | 5 | IPR001314 | |
| Domain | LRRC8_Pannexin-like | 2.33e-04 | 5 | 91 | 2 | IPR021040 | |
| Domain | Pannexin_like | 2.33e-04 | 5 | 91 | 2 | PF12534 | |
| Domain | Folate_rcpt | 2.33e-04 | 5 | 91 | 2 | IPR004269 | |
| Domain | TRYPSIN_DOM | 2.47e-04 | 115 | 91 | 5 | PS50240 | |
| Domain | Tryp_SPc | 2.68e-04 | 117 | 91 | 5 | SM00020 | |
| Domain | WD40 | 2.73e-04 | 259 | 91 | 7 | PF00400 | |
| Domain | Trypsin | 3.13e-04 | 121 | 91 | 5 | PF00089 | |
| Domain | Trypsin_dom | 3.13e-04 | 121 | 91 | 5 | IPR001254 | |
| Domain | Peptidase_S1_PA | 3.38e-04 | 123 | 91 | 5 | IPR009003 | |
| Domain | WD_REPEATS_1 | 4.19e-04 | 278 | 91 | 7 | PS00678 | |
| Domain | WD40_repeat_dom | 6.20e-04 | 297 | 91 | 7 | IPR017986 | |
| Domain | Folate_rcpt-like | 6.45e-04 | 8 | 91 | 2 | IPR018143 | |
| Domain | DHC_N1 | 6.45e-04 | 8 | 91 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 6.45e-04 | 8 | 91 | 2 | IPR013594 | |
| Domain | Folate_rec | 6.45e-04 | 8 | 91 | 2 | PF03024 | |
| Domain | TRYPSIN_SER | 9.79e-04 | 90 | 91 | 4 | IPR033116 | |
| Domain | TRYPSIN_HIS | 1.61e-03 | 103 | 91 | 4 | IPR018114 | |
| Domain | HSP70_2 | 3.04e-03 | 17 | 91 | 2 | PS00329 | |
| Domain | HSP70_3 | 3.04e-03 | 17 | 91 | 2 | PS01036 | |
| Domain | HSP70_1 | 3.04e-03 | 17 | 91 | 2 | PS00297 | |
| Domain | Hsp_70_fam | 3.41e-03 | 18 | 91 | 2 | IPR013126 | |
| Domain | AAA+_ATPase | 5.39e-03 | 144 | 91 | 4 | IPR003593 | |
| Domain | AAA | 5.39e-03 | 144 | 91 | 4 | SM00382 | |
| Domain | IPT | 7.61e-03 | 27 | 91 | 2 | SM00429 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 2.17e-13 | 5 | 104 | 5 | 12629516 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-8 ERVK-18 ERVK-19 ERVK-25 ERVK-24 | 2.69e-13 | 94 | 104 | 10 | 21542922 |
| Pubmed | 1.11e-11 | 18 | 104 | 6 | 18664271 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 7.54e-11 | 4 | 104 | 4 | 10469592 | |
| Pubmed | 1.69e-10 | 12 | 104 | 5 | 14557543 | ||
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 10516026 | ||
| Pubmed | Characterization of genes encoding known and novel human mast cell tryptases on chromosome 16p13.3. | 2.60e-08 | 3 | 104 | 3 | 9920877 | |
| Pubmed | 2.60e-08 | 3 | 104 | 3 | 19748655 | ||
| Pubmed | 1.04e-07 | 4 | 104 | 3 | 7983737 | ||
| Pubmed | 5.16e-07 | 6 | 104 | 3 | 15063128 | ||
| Pubmed | New developments in the genetics and activation of mast cell proteases. | 5.16e-07 | 6 | 104 | 3 | 12217407 | |
| Pubmed | 3.07e-06 | 10 | 104 | 3 | 12970426 | ||
| Pubmed | The structure of the human betaII-tryptase tetramer: fo(u)r better or worse. | 8.86e-06 | 2 | 104 | 2 | 10500112 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 18668540 | ||
| Pubmed | Characterization of a tryptase mRNA expressed in the human basophil cell line KU812. | 8.86e-06 | 2 | 104 | 2 | 8434231 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 37511292 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 18854315 | ||
| Pubmed | Cloning and characterization of a second complementary DNA for human tryptase. | 8.86e-06 | 2 | 104 | 2 | 2203827 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 9060628 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 25060181 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 8.86e-06 | 2 | 104 | 2 | 9460924 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 10898108 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 9064323 | ||
| Pubmed | Essential role for mast cell tryptase in acute experimental colitis. | 8.86e-06 | 2 | 104 | 2 | 21173247 | |
| Pubmed | Mast Cell Protease 7 Promotes Angiogenesis by Degradation of Integrin Subunits. | 8.86e-06 | 2 | 104 | 2 | 31013764 | |
| Pubmed | Human beta-tryptase is a ring-like tetramer with active sites facing a central pore. | 8.86e-06 | 2 | 104 | 2 | 9521329 | |
| Pubmed | Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family. | 8.86e-06 | 2 | 104 | 2 | 2187193 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 12391231 | ||
| Pubmed | Natural disruption of the mouse mast cell protease 7 gene in the C57BL/6 mouse. | 8.86e-06 | 2 | 104 | 2 | 8576265 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 15567416 | ||
| Pubmed | Two Hsp70 family members expressed in atherosclerotic lesions. | 8.86e-06 | 2 | 104 | 2 | 12552099 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 10391906 | ||
| Pubmed | The human mast cell tryptase tetramer: a fascinating riddle solved by structure. | 8.86e-06 | 2 | 104 | 2 | 10708850 | |
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 17449330 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 9395536 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 31337736 | ||
| Pubmed | 8.86e-06 | 2 | 104 | 2 | 12100045 | ||
| Pubmed | Identification and molecular cloning of a novel mouse mucosal mast cell serine protease. | 8.86e-06 | 2 | 104 | 2 | 1688433 | |
| Pubmed | Lack of expression of the tryptase mouse mast cell protease 7 in mast cells of the C57BL/6J mouse. | 8.86e-06 | 2 | 104 | 2 | 8077672 | |
| Pubmed | Isolation, characterization, and transcription of the gene encoding mouse mast cell protease 7. | 8.86e-06 | 2 | 104 | 2 | 1454796 | |
| Pubmed | Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. | 8.86e-06 | 2 | 104 | 2 | 11672541 | |
| Pubmed | Transcriptional regulation of mouse mast cell protease-7 by TGF-beta. | 8.86e-06 | 2 | 104 | 2 | 16730810 | |
| Pubmed | 9.23e-06 | 14 | 104 | 3 | 9373155 | ||
| Pubmed | 1.15e-05 | 15 | 104 | 3 | 14576168 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 33618608 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 8304978 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 1894617 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 9166787 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 9971820 | ||
| Pubmed | Renal tubular reabsorption of folate mediated by folate binding protein 1. | 2.65e-05 | 3 | 104 | 2 | 15703271 | |
| Pubmed | The expression pattern of three mast cell specific proteases during mouse development. | 2.65e-05 | 3 | 104 | 2 | 16777228 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 15694460 | ||
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 9541598 | ||
| Pubmed | Expression patterns of folate binding proteins one and two in the developing mouse embryo. | 2.65e-05 | 3 | 104 | 2 | 9973545 | |
| Pubmed | Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development. | 2.65e-05 | 3 | 104 | 2 | 10508523 | |
| Pubmed | 2.65e-05 | 3 | 104 | 2 | 11157480 | ||
| Pubmed | Protective role of protease-activated receptor-2 in anaphylaxis model mice. | 2.65e-05 | 3 | 104 | 2 | 38635782 | |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 27122634 | ||
| Pubmed | LRRC8 Proteins Form Volume-Regulated Anion Channels that Sense Ionic Strength. | 5.29e-05 | 4 | 104 | 2 | 26824658 | |
| Pubmed | Murine implantation serine proteinases 1 and 2: structure, function and evolution. | 5.29e-05 | 4 | 104 | 2 | 16257142 | |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 18930956 | ||
| Pubmed | Identification of two putative novel folate receptor genes in humans and mouse. | 5.29e-05 | 4 | 104 | 2 | 11111049 | |
| Pubmed | Role of metazoan mediator proteins in interferon-responsive transcription. | 5.29e-05 | 4 | 104 | 2 | 12509459 | |
| Pubmed | Linkage analysis of susceptibility to ozone-induced lung inflammation in inbred mice. | 5.29e-05 | 4 | 104 | 2 | 9398854 | |
| Pubmed | Mutations in folate transporter genes and risk for human myelomeningocele. | 5.29e-05 | 4 | 104 | 2 | 28948692 | |
| Pubmed | LRRC8A:C/E Heteromeric Channels Are Ubiquitous Transporters of cGAMP. | 5.29e-05 | 4 | 104 | 2 | 33171122 | |
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 20683905 | ||
| Pubmed | 5.29e-05 | 4 | 104 | 2 | 11175280 | ||
| Pubmed | 7.44e-05 | 233 | 104 | 6 | 37704626 | ||
| Pubmed | Renal Deletion of LRRC8/VRAC Channels Induces Proximal Tubulopathy. | 8.80e-05 | 5 | 104 | 2 | 35777784 | |
| Pubmed | Genetic linkage analysis of susceptibility to particle exposure in mice. | 8.80e-05 | 5 | 104 | 2 | 10783129 | |
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 8.80e-05 | 5 | 104 | 2 | 11401426 | |
| Pubmed | LRRC8 involved in B cell development belongs to a novel family of leucine-rich repeat proteins. | 8.80e-05 | 5 | 104 | 2 | 15094057 | |
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 24790029 | ||
| Pubmed | Pulmonary mastocytosis and enhanced lung inflammation in mice heterozygous null for the Foxf1 gene. | 8.80e-05 | 5 | 104 | 2 | 18421012 | |
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 10843716 | ||
| Pubmed | Mast cells contribute to autoimmune inflammatory arthritis via their tryptase/heparin complexes. | 8.80e-05 | 5 | 104 | 2 | 19109198 | |
| Pubmed | Elastase and tryptase govern TNFα-mediated production of active chemerin by adipocytes. | 8.80e-05 | 5 | 104 | 2 | 23227233 | |
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 14527958 | ||
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 32332915 | ||
| Pubmed | 8.80e-05 | 5 | 104 | 2 | 17132730 | ||
| Pubmed | 8.97e-05 | 29 | 104 | 3 | 14638676 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FAM193B LRWD1 MED14 STK32C EDC4 MST1R THADA DNAJC14 SUMF1 ZFYVE26 MMP17 WNK2 | 1.17e-04 | 1105 | 104 | 12 | 35748872 |
| Pubmed | 1.32e-04 | 6 | 104 | 2 | 20021265 | ||
| Pubmed | Folate transport in mouse cumulus-oocyte complexes and preimplantation embryos. | 1.32e-04 | 6 | 104 | 2 | 23904512 | |
| Pubmed | 1.84e-04 | 7 | 104 | 2 | 23471985 | ||
| Pubmed | 1.84e-04 | 7 | 104 | 2 | 9256245 | ||
| Pubmed | 1.84e-04 | 7 | 104 | 2 | 12915301 | ||
| Pubmed | Location of the mouse mast cell protease 7 gene (Mcpt7) to chromosome 17. | 2.45e-04 | 8 | 104 | 2 | 7849408 | |
| Pubmed | 2.45e-04 | 8 | 104 | 2 | 16774856 | ||
| Pubmed | 2.45e-04 | 8 | 104 | 2 | 22365888 | ||
| Pubmed | 3.14e-04 | 9 | 104 | 2 | 9989412 | ||
| Pubmed | 3.14e-04 | 9 | 104 | 2 | 14636573 | ||
| Pubmed | 3.14e-04 | 9 | 104 | 2 | 12101254 | ||
| Pubmed | Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. | 3.14e-04 | 9 | 104 | 2 | 8710870 | |
| Pubmed | 3.51e-04 | 730 | 104 | 9 | 34857952 | ||
| Pubmed | A coregulatory role for the TRAP-mediator complex in androgen receptor-mediated gene expression. | 3.92e-04 | 10 | 104 | 2 | 12218053 | |
| Pubmed | 3.92e-04 | 10 | 104 | 2 | 14583634 | ||
| Pubmed | Necdin promotes ubiquitin-dependent degradation of PIAS1 SUMO E3 ligase. | 4.79e-04 | 11 | 104 | 2 | 24911587 | |
| Pubmed | Transcription coactivator TRAP220 is required for PPAR gamma 2-stimulated adipogenesis. | 4.79e-04 | 11 | 104 | 2 | 12037571 | |
| GeneFamily | WD repeat domain containing | 1.98e-05 | 262 | 58 | 7 | 362 | |
| GeneFamily | Dyneins, axonemal | 2.06e-05 | 17 | 58 | 3 | 536 | |
| GeneFamily | Volume regulated anion channel subunits | 1.01e-04 | 5 | 58 | 2 | 1158 | |
| GeneFamily | Heat shock 70kDa proteins | 1.33e-03 | 17 | 58 | 2 | 583 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.03e-09 | 162 | 94 | 8 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 6.56e-09 | 188 | 94 | 8 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-08 | 145 | 94 | 7 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.24e-08 | 169 | 94 | 7 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.50e-08 | 173 | 94 | 7 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.11e-07 | 180 | 94 | 7 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.16e-07 | 181 | 94 | 7 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.44e-07 | 187 | 94 | 7 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.50e-07 | 188 | 94 | 7 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.55e-07 | 189 | 94 | 7 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.55e-07 | 189 | 94 | 7 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease state, Lineage and Cell class | 1.55e-07 | 189 | 94 | 7 | c007fccd08728db3ea99af9da91d67b9b16dabb3 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 1.55e-07 | 189 | 94 | 7 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.67e-07 | 191 | 94 | 7 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.67e-07 | 191 | 94 | 7 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.67e-07 | 191 | 94 | 7 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.73e-07 | 192 | 94 | 7 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.85e-07 | 194 | 94 | 7 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-07 | 194 | 94 | 7 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.92e-07 | 195 | 94 | 7 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.06e-07 | 197 | 94 | 7 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.06e-07 | 197 | 94 | 7 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.06e-07 | 197 | 94 | 7 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.06e-07 | 197 | 94 | 7 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.13e-07 | 198 | 94 | 7 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.20e-07 | 199 | 94 | 7 | 92778939e9d06599c7d06cfd8f4362b97ed0606b | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.28e-07 | 200 | 94 | 7 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.28e-07 | 200 | 94 | 7 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.95e-06 | 175 | 94 | 6 | cd42020fe57afeaadfbd3ef6d7375e66d71e9669 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-06 | 175 | 94 | 6 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | Ciliated_cells-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.08e-06 | 177 | 94 | 6 | c38138fb5ad9766c2d240811210c854338cd612e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-06 | 178 | 94 | 6 | c20f050344a2e120e685e2a7fe36c6dfc1dc37b6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.15e-06 | 178 | 94 | 6 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.29e-06 | 180 | 94 | 6 | adf5db5bfa9a38b1227ab0beccd8d6f3eea67ac0 | |
| ToppCell | facs-GAT-Fat-3m-Epithelial-epithelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-06 | 181 | 94 | 6 | e97cbaafb93fdbee8e3cf4a06e6bcf121d941403 | |
| ToppCell | facs-GAT-Fat-3m-Epithelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-06 | 181 | 94 | 6 | 11cb84528f7ca084f0a92eda4f2e18e63a428fe9 | |
| ToppCell | -Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.37e-06 | 181 | 94 | 6 | ef579e958f334da0f9415aa7e3d5c02c807954a6 | |
| ToppCell | facs-GAT-Fat-3m-Epithelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-06 | 181 | 94 | 6 | 5ffeca29e4d31a20c110d27af128ed024a79ad56 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 2.45e-06 | 182 | 94 | 6 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Ciliated_cells-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.60e-06 | 184 | 94 | 6 | 07c5a9633ccdcd18771e3230d6198a55c400afa6 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.60e-06 | 184 | 94 | 6 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-06 | 185 | 94 | 6 | ca69499ba8c39b7ed6717d05685d6f70066a77bd | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.69e-06 | 185 | 94 | 6 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.69e-06 | 185 | 94 | 6 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 2.69e-06 | 185 | 94 | 6 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | Ciliated_cells-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 2.77e-06 | 186 | 94 | 6 | f72267d533fd0c5280d9741ceee3dd116300a7e4 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.77e-06 | 186 | 94 | 6 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 2.86e-06 | 187 | 94 | 6 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-06 | 188 | 94 | 6 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | Ciliated_cells-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 2.95e-06 | 188 | 94 | 6 | 606907c865bd2f11bb6474932716550f7723d858 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.95e-06 | 188 | 94 | 6 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.04e-06 | 189 | 94 | 6 | dc440015949a768188c67661b6be63b1ead1a0f0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.04e-06 | 189 | 94 | 6 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.04e-06 | 189 | 94 | 6 | 1ecf9911ff82e0ca0f0c101b735d3b1f3b339d57 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.04e-06 | 189 | 94 | 6 | b4b93bd10b7e3cc16e54ff73beac230f519c010a | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 3.04e-06 | 189 | 94 | 6 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 3.04e-06 | 189 | 94 | 6 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-06 | 191 | 94 | 6 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.23e-06 | 191 | 94 | 6 | e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.43e-06 | 193 | 94 | 6 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 3.43e-06 | 193 | 94 | 6 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-06 | 193 | 94 | 6 | ffa1932da2979d7b63dbac32eb5788346a3f5b2a | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 3.53e-06 | 194 | 94 | 6 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 3.53e-06 | 194 | 94 | 6 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.64e-06 | 195 | 94 | 6 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 | |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.64e-06 | 195 | 94 | 6 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.64e-06 | 195 | 94 | 6 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.64e-06 | 195 | 94 | 6 | fb3dc2c8fd125f23d0c3aa211520778aac8d6dda | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.64e-06 | 195 | 94 | 6 | 3e70ee987d66d450062d5df3d7c733ccc7344470 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 3.75e-06 | 196 | 94 | 6 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 3.75e-06 | 196 | 94 | 6 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | Goblet_cell|World / shred on cell type and cluster | 3.86e-06 | 197 | 94 | 6 | d82d3204f24c95771c1496c28e3fbc6e2442199b | |
| ToppCell | C_04|World / shred on cell type and cluster | 3.86e-06 | 197 | 94 | 6 | 885604356e19a850b0e601c3167ad26b8180bcec | |
| ToppCell | COVID-19-Epithelial|COVID-19 / Condition, Lineage and Cell class | 3.86e-06 | 197 | 94 | 6 | 18fd7344628a87d5c7ef5efb66e260a4136245bf | |
| ToppCell | distal-Epithelial-Ciliated-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.09e-06 | 199 | 94 | 6 | 2de1fe124737a6cca4b3805ab3056f9d9d7c16c7 | |
| ToppCell | 3'_v3-Lung-Myeloid_Monocytic|Lung / Manually curated celltypes from each tissue | 4.09e-06 | 199 | 94 | 6 | 3e14f9a62d6414add8d5f681be184b4625001838 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.09e-06 | 199 | 94 | 6 | 2498237b9e895ca4826a3378d9d40989968df72b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.09e-06 | 199 | 94 | 6 | 542ec45c931b40738df1f3777b00c83be33a514a | |
| ToppCell | Biopsy_Other_PF-Epithelial-Differentiating_Ciliated|Biopsy_Other_PF / Sample group, Lineage and Cell type | 4.21e-06 | 200 | 94 | 6 | f7b4581d958afbd68f9045af619aaca0ab463439 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.21e-06 | 200 | 94 | 6 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Club|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 4.21e-06 | 200 | 94 | 6 | 292c63693eb7f435335a8cfba07aa35b72139393 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Differentiating_Ciliated|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 4.21e-06 | 200 | 94 | 6 | a552a99f5e4fa00dfb7775e5a3e1f62f1530d104 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.21e-06 | 200 | 94 | 6 | e1dce91c6c531bb212002a14705e496d77ad3490 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.21e-06 | 200 | 94 | 6 | f1a49bc818054fb0734d3b84725ee6487b034567 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Club|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 4.21e-06 | 200 | 94 | 6 | 85f946dd3831acf3488c87efba96689cc2667c3a | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Ciliated|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 4.21e-06 | 200 | 94 | 6 | d7ae09189cf0b7e2f7e7fc6b0921975b75aa7d62 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.21e-06 | 200 | 94 | 6 | ddd39b754bfaa98249d497dfb7e97ec58617a11a | |
| ToppCell | Biopsy_IPF-Epithelial|Biopsy_IPF / Sample group, Lineage and Cell type | 4.21e-06 | 200 | 94 | 6 | 76f1ac00b34d07057d8da03d276438b719b46b1d | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Ciliated|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.21e-06 | 200 | 94 | 6 | a521cf837cadf280505ff9d7e641a205af7d6513 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.21e-06 | 200 | 94 | 6 | 918b576fd9491d23c2bb9d663fa5fb3505cb1c7e | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.21e-06 | 200 | 94 | 6 | 8a44a4f7ea9358f2194a490e79601c98ff7fdcb0 | |
| ToppCell | Biopsy_IPF-Mesenchymal-HAS1_High_Fibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 4.21e-06 | 200 | 94 | 6 | d02e256b5d65a5c982ba5696bc7e077281ca3e24 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Club|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.21e-06 | 200 | 94 | 6 | 30d428510c68da96c7c8cfd472f449ebb9631132 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.21e-06 | 200 | 94 | 6 | cf59110547cc66b5f4a2999735336b0309ba9b0d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.72e-05 | 151 | 94 | 5 | 7b50425d2bbd7b6ff2a6e67d3e2470a4455740e0 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 1.72e-05 | 151 | 94 | 5 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 153 | 94 | 5 | 83942ef63d21725fa15ed5a91481d1f9936e8f11 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-05 | 158 | 94 | 5 | 1cefb82b9bf79c687a119be568cfc15b14c6e040 | |
| ToppCell | Ciliated_cells-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.56e-05 | 164 | 94 | 5 | 0e9961acbb1d6c0089e6805ba6756736fa4d8bed | |
| ToppCell | Multiple_Sclerosis-Other-HSPC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 2.56e-05 | 164 | 94 | 5 | 6af5529507d695b347adee4be5ead70f56c9cf55 | |
| Drug | Brunfelsamidine | 2.81e-07 | 4 | 95 | 3 | CID005281683 | |
| Drug | ioxaglate | 2.43e-06 | 7 | 95 | 3 | CID000003742 | |
| Drug | Telebrix | 2.43e-06 | 7 | 95 | 3 | CID000034536 | |
| Drug | daphnodorin C | 5.80e-06 | 9 | 95 | 3 | CID000072428 | |
| Drug | AC1NUP69 | 8.27e-06 | 10 | 95 | 3 | CID005487154 | |
| Drug | 1c5s | 8.27e-06 | 10 | 95 | 3 | CID000444753 | |
| Drug | pimaradiene | 1.13e-05 | 11 | 95 | 3 | CID000440909 | |
| Drug | Z-ala-ala-lys-mna | 1.13e-05 | 11 | 95 | 3 | CID005486901 | |
| Drug | daphnodorin A | 1.13e-05 | 11 | 95 | 3 | CID000072426 | |
| Drug | AC1NSU64 | 1.13e-05 | 11 | 95 | 3 | CID005316303 | |
| Drug | methylhistamine | 1.13e-05 | 11 | 95 | 3 | CID000000912 | |
| Drug | bis(5-amidino-2-benzimidazolyl)methane | 1.51e-05 | 12 | 95 | 3 | CID000002386 | |
| Drug | Elocom | 1.51e-05 | 12 | 95 | 3 | CID000123620 | |
| Drug | 4-amidinophenylpyruvic acid | 1.51e-05 | 12 | 95 | 3 | CID000151496 | |
| Drug | NSC-648146 | 1.51e-05 | 12 | 95 | 3 | CID000372649 | |
| Drug | Trazodone hydrochloride [25332-39-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.72e-05 | 194 | 95 | 7 | 7410_UP | |
| Drug | AC1NUV1X | 1.72e-05 | 2 | 95 | 2 | CID005494401 | |
| Drug | Protriptyline hydrochloride [1225-55-4]; Down 200; 13.4uM; HL60; HT_HG-U133A | 1.78e-05 | 195 | 95 | 7 | 3119_DN | |
| Drug | Z-ARR-AFC | 1.95e-05 | 13 | 95 | 3 | CID000125067 | |
| Drug | Nk3201 | 1.95e-05 | 13 | 95 | 3 | CID000213050 | |
| Drug | 2-Chloropyrazine [14508-49-7]; Down 200; 35uM; PC3; HT_HG-U133A | 2.09e-05 | 200 | 95 | 7 | 5750_DN | |
| Drug | Artemisinin [63968-64-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 2.09e-05 | 200 | 95 | 7 | 7007_UP | |
| Drug | ABPH | 2.48e-05 | 14 | 95 | 3 | CID000092377 | |
| Drug | Aa1 | 2.55e-05 | 83 | 95 | 5 | CID009549188 | |
| Drug | FdTTP | 3.09e-05 | 15 | 95 | 3 | CID000162005 | |
| Drug | thymidine glycol | 3.79e-05 | 16 | 95 | 3 | CID003035041 | |
| Drug | (E)-4-aminohex-4-enoic acid | 3.79e-05 | 16 | 95 | 3 | CID005288385 | |
| Drug | methylimidazoleacetic acid | 4.59e-05 | 17 | 95 | 3 | CID000075810 | |
| Drug | H 17 | 4.59e-05 | 17 | 95 | 3 | CID000476867 | |
| Drug | thymidine glycol monophosphate | 5.15e-05 | 3 | 95 | 2 | CID000165415 | |
| Drug | 2D7 | 5.22e-05 | 49 | 95 | 4 | CID005327103 | |
| Drug | 2-azetidinone | 5.49e-05 | 18 | 95 | 3 | CID000136721 | |
| Drug | A80a | 7.62e-05 | 20 | 95 | 3 | CID005487000 | |
| Drug | 4-oh-8-o-2'dg | 7.62e-05 | 20 | 95 | 3 | CID000126256 | |
| Drug | AC1L1E6H | 7.67e-05 | 54 | 95 | 4 | CID000002661 | |
| Drug | AC1LTNWX | 1.02e-04 | 58 | 95 | 4 | CID001536427 | |
| Drug | atracurium besylate | 1.02e-04 | 22 | 95 | 3 | CID000047320 | |
| Drug | Kinetensin | 1.17e-04 | 23 | 95 | 3 | CID000147043 | |
| Drug | fenpropathrin | 1.32e-04 | 62 | 95 | 4 | CID000047326 | |
| Drug | PL 0 | 1.34e-04 | 24 | 95 | 3 | CID000016157 | |
| Drug | S)-bromoenol lactone | 1.43e-04 | 119 | 95 | 5 | CID000002445 | |
| Drug | CAS 79547-78-7 | 1.51e-04 | 25 | 95 | 3 | CID000003915 | |
| Drug | CAS 83919-23-7 | 1.71e-04 | 26 | 95 | 3 | CID000004240 | |
| Drug | tetrachlorophthalimide | 1.71e-04 | 5 | 95 | 2 | CID000074077 | |
| Drug | 7-CEGua | 1.71e-04 | 5 | 95 | 2 | CID000150878 | |
| Drug | A821880 | 1.71e-04 | 5 | 95 | 2 | CID005040205 | |
| Drug | Chloroquine diphosphate [50-63-5]; Down 200; 7.8uM; PC3; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 7251_DN | |
| Drug | Zimelidine dihydrochloride monohydrate [61129-30-4]; Up 200; 9.8uM; PC3; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 4609_UP | |
| Drug | Ricinine [524-40-3]; Up 200; 24.4uM; HL60; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 2505_UP | |
| Drug | Scopolamine hydrochloride [55-16-3]; Up 200; 11.8uM; HL60; HT_HG-U133A | 1.83e-04 | 198 | 95 | 6 | 3018_UP | |
| Drug | Etidronic acid, disodium salt [7414-83-7]; Up 200; 16uM; HL60; HT_HG-U133A | 1.88e-04 | 199 | 95 | 6 | 2985_UP | |
| Drug | estradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A | 1.88e-04 | 199 | 95 | 6 | 7000_DN | |
| Drug | 2-methylundecanal | 1.91e-04 | 27 | 95 | 3 | CID000061031 | |
| Drug | Procaine hydrochloride [51-05-8]; Up 200; 14.6uM; PC3; HT_HG-U133A | 1.94e-04 | 200 | 95 | 6 | 6329_UP | |
| Disease | tryptase beta-2 measurement | 2.51e-06 | 9 | 93 | 3 | EFO_0008306 | |
| Disease | Osteosarcoma | 1.49e-05 | 47 | 93 | 4 | C0029463 | |
| Disease | Colorectal Carcinoma | CYP1B1 DNAH3 ABCA13 NTHL1 HTR3C CHD1 STK32C PPM1F PKHD1 TENM1 | 7.46e-05 | 702 | 93 | 10 | C0009402 |
| Disease | Combined immunodeficiency | 2.96e-04 | 41 | 93 | 3 | C0494261 | |
| Disease | hip bone mineral density | 6.90e-04 | 126 | 93 | 4 | EFO_0007702 | |
| Disease | basophil measurement | 9.11e-04 | 60 | 93 | 3 | EFO_0803539 | |
| Disease | glucose measurement | 1.30e-03 | 380 | 93 | 6 | EFO_0004468 | |
| Disease | urticaria | 1.80e-03 | 20 | 93 | 2 | EFO_0005531 | |
| Disease | systemic mastocytosis | 2.81e-03 | 25 | 93 | 2 | MONDO_0016586 | |
| Disease | Impaired glucose tolerance | 2.81e-03 | 25 | 93 | 2 | C0271650 | |
| Disease | visuospatial function measurement | 3.04e-03 | 26 | 93 | 2 | EFO_0803533 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ERKWEVPLLPQNGFW | 376 | Q96KV6 | |
| GIAAKWWNPPQEKTI | 236 | Q9Y2D5 | |
| LQVWQGLAWARAPQP | 476 | Q96LX7 | |
| VVCDQKLRPNIPNWW | 446 | P36896 | |
| KLRPNIPNWWQSYEA | 451 | P36896 | |
| WWVNNQSLPVSPRLQ | 356 | P06731 | |
| RWPLVIDPQQQGIKW | 3491 | Q96DT5 | |
| WKLQSLLQNLPQWPA | 426 | Q86UQ4 | |
| MDLVWDNPFINWNPK | 91 | Q8WXA8 | |
| NVNGLKAQPWWTPKE | 566 | Q12797 | |
| NTVPPVLNDWKCVWQ | 151 | Q8TDJ6 | |
| PWWQVFNDDLTKPII | 216 | Q8N1B3 | |
| TNPEQIKQWRKNLWI | 1466 | O14646 | |
| PPEDWPALIWQQQRE | 946 | Q6P2E9 | |
| LQAPTQILKWPQPWA | 596 | Q9UFC0 | |
| QILKWPQPWALGQVV | 601 | Q9UFC0 | |
| EWQKRGGQPWQLIEP | 511 | P28039 | |
| KENWIDPLMRWQPEV | 146 | D6REC4 | |
| QRPWQLAQELEPQSW | 4636 | Q99102 | |
| WGWLELPWVKQNINR | 396 | Q6Y2X3 | |
| NIDPVVWTNQRVLKW | 606 | Q674X7 | |
| AWQNPVAWQNPVIWP | 331 | Q9Y5V3 | |
| VAWQNPVIWPNPVIW | 336 | Q9Y5V3 | |
| PRPWENLNLSDWEVQ | 911 | Q9UJ55 | |
| PFLPNWQPVQWHSKV | 221 | O14920 | |
| PQQARPPFQKWIWMN | 121 | Q9Y231 | |
| KVIVWDWVRQRPVLN | 251 | P0C7V8 | |
| WVQPWRCTLQPVLEN | 301 | A0A0J9YXQ4 | |
| WWAVAPENKVIGQQP | 576 | A0A1B0GTH6 | |
| RLGIPKNPWLWSEQQ | 96 | P15036 | |
| QKAQEEPQWVPATWI | 616 | Q96JB8 | |
| WAKPLSQLWQNRPPN | 636 | O75164 | |
| SRPCQTQKPQKPWWE | 221 | P06239 | |
| LWDVQNPRVKLISWP | 166 | Q9P104 | |
| PNLGPWIRQVNQSWR | 111 | P41439 | |
| NAWRPQVNNPKEWLQ | 2236 | P00451 | |
| VKFQPSLWPWDSVRN | 86 | Q9NVC6 | |
| DVRWVITVPAIWKQP | 196 | O43301 | |
| VRWVLTVPAIWKQPA | 201 | Q96MM6 | |
| IPWSPNRQWDEQLDP | 626 | P42694 | |
| VVKTDSQQPLVWPAW | 261 | Q05925 | |
| PWIQQLKFWLGQQRC | 491 | O60244 | |
| WAWLPQAKVPFSQEI | 366 | Q9BTU6 | |
| FWNPTPDIKQWRLIR | 656 | Q9BZF1 | |
| QPQEGFWKRPPQRWS | 586 | Q9H7U1 | |
| QIPWDRNPEALAKWA | 336 | Q49AN0 | |
| KVPRNHWVLQWPGQV | 1271 | Q8TD57 | |
| WRNWPGEAKARPQEQ | 796 | Q96PV7 | |
| AERQLQVQWEPPGSW | 141 | Q14213 | |
| PAAPGAWRQQIQWEN | 36 | P28300 | |
| PQKHLGPVWQLQWIE | 581 | Q5VTH9 | |
| WLTRILKPWPMVNQA | 236 | Q5MNV8 | |
| WQINNQEKSWQRPPL | 181 | Q6PJQ5 | |
| FVNQWSVNHDPLKWP | 421 | Q16678 | |
| WLAAAQRKDPEQAWL | 666 | Q5T1A1 | |
| HLWKQNTVNPREWTP | 366 | Q6IA86 | |
| VKLVRLRNPWGQVEW | 351 | P20807 | |
| NKRNQWVPWSKLVPE | 2401 | Q8IVF4 | |
| QWEIFPPQSWKLALV | 196 | Q3KQZ1 | |
| QQDALAQPQPWWKTQ | 16 | A0AV02 | |
| WCIPESPRWLISQNK | 281 | O15244 | |
| PNLGPWIQQVDQSWR | 111 | P15328 | |
| NDIQPTYRILKPWWD | 11 | Q7L1W4 | |
| NRLWEVAGQWQKQVP | 131 | P49593 | |
| NITAPKTQGLRWPWQ | 451 | Q6UXH9 | |
| PIWIGLHDPQKRQQW | 91 | Q9BYZ8 | |
| QWSLWPEIPCNLIAK | 46 | A5PLK6 | |
| KAQWPAWQPLNVRAA | 286 | Q9HCB6 | |
| EAPRSKWPWQVSLRV | 36 | Q15661 | |
| EAPRSKWPWQVSLRV | 36 | P20231 | |
| GQEAPRSKWPWQVSL | 41 | Q9BZJ3 | |
| CPNVSLQKLPEQWLW | 1126 | Q6YHU6 | |
| QAPAPTKWNKRNLSW | 126 | Q9ULZ9 | |
| KRRWNEEPWESPAQV | 261 | O94761 | |
| PLKVPVWEPQDWQQQ | 81 | P78549 | |
| EPNQFVQPAWQIVLW | 21 | P25103 | |
| PEKRTLWLPWNQFIV | 946 | Q9UKZ4 | |
| NIPNAVWVWDIQKLR | 351 | Q9P2S5 | |
| EPNQWPQEPWHKVRN | 3251 | P08F94 | |
| RLQQAPPCVWWKATS | 141 | Q8N4L1 | |
| QQAVAAAPWWLPVKG | 171 | Q8NBK3 | |
| SIIALNQWPKNWPKQ | 811 | P63128 | |
| VRSQPRPLFQWSKWK | 51 | Q86UX6 | |
| KGQWRWVDQTPFNPR | 151 | Q8WXI8 | |
| VSIIALNQWPKNWPK | 31 | P63127 | |
| VSIIALNQWPKNWPK | 31 | P63129 | |
| WPWKDAPIRTLVQRI | 31 | Q96EN9 | |
| PPAVWNAEQQRILWK | 741 | Q9BQI5 | |
| VSIIALNQWPKNWPK | 31 | P63121 | |
| LWRPRPSQTQWQRKL | 1071 | A6NE52 | |
| QSPWEIAAQWVVPRE | 61 | O75063 | |
| VSIIALNQWPKNWPK | 31 | P63131 | |
| DLDWNPKVSTLNVWP | 1291 | Q96K76 | |
| VSIIALNQWPKNWPK | 31 | Q9Y6I0 | |
| VSIIALNQWPKNWPK | 31 | P63125 | |
| WAPPPQHNFLKNWQR | 196 | Q8TBZ2 | |
| PNWSILPEEERNIQW | 331 | Q15814 | |
| VSIIALNQWPKNWPK | 31 | P10265 | |
| VSIIALNQWPKNWPK | 31 | P63123 | |
| WRRERIWPALQPKEQ | 541 | Q9Y3S1 | |
| VSIIALNQWPKNWPK | 31 | P63122 | |
| NPQRVAWVWLLVLEK | 71 | Q68DK2 | |
| WWRRKQLVLPPNLND | 981 | Q04912 | |
| ALWNKCREPLNVVPW | 141 | P48230 | |
| VSIIALNQWPKNWPK | 31 | P63119 | |
| IQWLKAVQRDNWTPT | 36 | Q8WY91 | |
| VIAPKAAWPWQASLQ | 191 | Q6ZMR5 | |
| VSIIALNQWPKNWPK | 31 | P63124 | |
| VSIIALNQWPKNWPK | 31 | P63120 | |
| SEQQPAFRVLKPWWD | 11 | Q8TDW0 | |
| TWKNPSIPNVLRWLI | 71 | Q6IQ20 | |
| DAWGLNVALEWKPPQ | 1076 | Q14896 |